New to Meducation?
Already signed up?
Add To Boards
DNA blood test detects lung cancer mutations
Circulating tumor DNA in blood a valid option for EGFR testing in patients who do not have accessible tumor tissue, study showsCancer DNA circulating in the bloodstream...
Help by adding tags...
One in four advanced lung cancer patients tested for EGFR mutations started on first-line treatment before test results available
- Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European...
ANS Drugs - Mind Map
Dual therapy's 1-2 punch knocks out drug-resistant lung cancer
- Unusual chance to study patient's residual tumor leads to new findingCapitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had...
EGFR Testing Not Done in 25% of Lung Cancer Patients
- Not all patients with advanced NSCLC undergo testing for the EGFR mutation, and for some patients who do undergo testing, therapy is initiated before the results are received.
FDA OKs Osimertinib for Specific Non-Small-Cell Lung Cancers
- A new drug is available for patients with non-small-cell lung cancer (NSCLC) who progress on epidermal growth-factor receptor inhibitors and who have a specific related mutation.